Inhibition of Vascular Adhesion Protein-1 for Treatment of Graft-Versus-Host Disease in Mice

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Shin MukaiKazuo Tsubota

Abstract

Graft-versus-host disease (GVHD) is a potentially lethal complication of hematopoietic stem cell transplantation (HSCT). GVHD comprises acute and chronic forms. To date, several approaches to treat acute GVHD or chronic GVHD have been reported. However, there is no literature precedent regarding all-in-one methods to address the 2 GVHD types. Severe inflammation in organs affected by GVHD is highly problematic, and vascular adhesion protein-1 (VAP-1) is known to be detrimentally involved in various inflammatory diseases. Based on the previous reports, we envisaged that there would be a link between GVHD and VAP-1, and we strived to create effective therapies for the 2 types of GVHD using a mouse model of GVHD. Our investigation indicated that expression of VAP-1 was elevated in organs disordered by GVHD. Hence, we subsequently attempted to block VAP-1 by using a novel inhibitor. Our results indicate that systemic injection of the inhibitor prevented aberrant influx of inflammatory cells into tissues and thereby mitigate GVHD-elicited inflammation and fibrosis. Collectively, our study suggests that the increased expression of VAP-1 is detrimentally associated with the development of GVHD and that the blockade of VAP-1 could be a...Continue Reading

References

Dec 1, 1993·The Journal of Experimental Medicine·M SalmiS Jalkanen
Jun 1, 2000·Dermatology : International Journal for Clinical and Investigative Dermatology·S SatoK Takehara
Feb 27, 2001·Blood·G B Vogelsang
Apr 18, 2003·Virchows Archiv : an International Journal of Pathology·Baljit SinghReinhard Pabst
Jun 16, 2005·QJM : Monthly Journal of the Association of Physicians·M DziadzioR Stratton
Oct 4, 2005·Nature Reviews. Immunology·Marko Salmi, Sirpa Jalkanen
Oct 4, 2005·Nature Reviews. Immunology·Ashley T Haase
Jan 10, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Howard M ShulmanGeorgia B Vogelsang
May 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Asha B PillaiSamuel Strober
Apr 26, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kousuke NodaAli Hafezi-Moghadam
May 28, 2008·Best Practice & Research. Clinical Haematology·Tomomi ToubaiPavan Reddy
Nov 11, 2008·European Journal of Immunology·Jan KissMarko Salmi
May 28, 2009·Blood·Afonso C VigoritoUNKNOWN National Institutes of Health
Jul 29, 2009·Experimental Eye Research·Kousuke NodaAli Hafezi-Moghadam
Sep 3, 2010·Transplantation·Hyoung-Kyu YoonChang-Ki Min
Mar 26, 2011·The American Journal of Pathology·Shintaro NakaoAli Hafezi-Moghadam
Jul 13, 2011·Immunology and Cell Biology·Rhodri Ceredig
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Carrie L KitkoKristin Baird
Apr 3, 2012·The Journal of Clinical Investigation·Ding AiAlan R Tall
Aug 21, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Matthew D McGeoughSusannah D Brydges
May 28, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tao WuDefu Zeng
Aug 15, 2013·The Journal of Pharmacology and Experimental Therapeutics·Jonathan S FootWolfgang Jarolimek
Dec 7, 2013·Journal of Medicinal Chemistry·Eva Bligt-LindénTiina A Salminen
Jun 11, 2014·Blood·Gérard Socié, Jerome Ritz
Nov 16, 2014·Blood·Mary E D Flowers, Paul J Martin
Apr 19, 2015·Respiratory Research·Heidi C SchilterWolfgang Jarolimek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.